Related references
Note: Only part of the references are listed.BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN AN OPEN-LABEL, LONG-TERM EXTENSION STUDY
Peter Taylor et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn's Disease
William J. Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Therapeutic Efficacy of Suppressing the JAK/STAT Pathway in Multiple Models of Experimental Autoimmune Encephalomyelitis
Yudong Liu et al.
JOURNAL OF IMMUNOLOGY (2014)
A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
W. C. Ports et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages
Ashish Bhattacharjee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Immune-mediated Mechanisms in the Pathoprogression of Amyotrophic Lateral Sclerosis
Weihua Zhao et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
BAFF Controls Neural Cell Survival through BAFF Receptor
Satoru Tada et al.
PLOS ONE (2013)
The many faces of Janus kinase
Matthew M. Seavey et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Biology and significance of the JAK/STAT signalling pathways
Hiu Kiu et al.
GROWTH FACTORS (2012)
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
Oleg Butovsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
R723, a selective JAK2 inhibitor, effectively treats JAK2V617F-induced murine myeloproliferative neoplasm
Kotaro Shide et al.
BLOOD (2011)
Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
David R. Beers et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
IFNγ triggers a LIGHT-dependent selective death of motoneurons contributing to the non-cell-autonomous effects of mutant SOD1
J. Aebischer et al.
CELL DEATH AND DIFFERENTIATION (2011)
BCR-ABL1—Negative Myeloproliferative Neoplasms: A Review of Molecular Biology, Diagnosis, and Treatment
Erik Vakil et al.
Clinical Lymphoma Myeloma & Leukemia (2011)
The potential role of JAK2/STAT3 pathway on the anti-apoptotic effect of recombinant human erythropoietin (rhEPO) after experimental traumatic brain injury of rats
Jinbing Zhao et al.
CYTOKINE (2011)
Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis
Satoru Tada et al.
JOURNAL OF NEUROINFLAMMATION (2011)
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis
Kristine L. Stump et al.
ARTHRITIS RESEARCH & THERAPY (2011)
The role of blood-brain barrier studies in the pharmaceutical industry
A Reichel
CURRENT DRUG METABOLISM (2006)
Induction of cyclooxygenase-2 in reactive glial cells by the CD40 pathway: relevance to amyotrophic lateral sclerosis
T Okuno et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Share Paper
